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Enterovirus D68 Infections 
Associated with Severe Respiratory 
Illness in Elderly Patients and 
Emergence of a Novel Clade in 
Hong Kong
Susanna K. P. Lau1,2,3,4,*, Cyril C. Y. Yip1,*, Pyrear Su-Hui Zhao1, Wang-Ngai Chow1, 
Kelvin K. W. To1,2,3,4, Alan K. L. Wu5, Kwok-Yung Yuen1,2,3,4 & Patrick C. Y. Woo1,2,3,4
Despite the recent emergence of enterovirus D68 (EV-D68), its clinical impact on adult population is 
less well defined. To better define the epidemiology of EV-D68, 6,800 nasopharyngeal aspirates (NPAs) 
from 2010–2014 were subject to EV-D68 detection by RT-PCR and sequencing of 5′UTR and partial 
VP1. EV-D68 was detected in 30 (0.44%) NPAs from 22 children and 8 adults/elderlies. Sixteen patients 
(including five elderly) (53%) had pneumonia and 13 (43%) patients were complicated by small airway 
disease exacerbation. Phylogenetic analysis of VP1, 2C and 3D regions showed four distinct lineages of 
EV-D68, clade A1, A2, B1 and B3, with adults/elderlies exclusively infected by clade A2. The potentially 
new clade, B3, has emerged in 2014, while strains closely related to recently emerged B1 strains in the 
United States were also detected as early as 2011 in Hong Kong. The four lineages possessed distinct aa 
sequence patterns in BC and DE loops. Amino acid residues 97 and 140, within BC and DE-surface loops 
of VP1 respectively, were under potential positive selection. EV-D68 infections in Hong Kong usually 
peak in spring/summer, though with a delayed autumn/winter peak in 2011. This report suggests that 
EV-D68 may cause severe respiratory illness in adults/elderlies with underlying co-morbidities.
Since the severe acute respiratory syndrome (SARS) epidemic, intensive research efforts have been made to 
identify novel causative agents of respiratory tract infections, leading to the discovery of various novel viruses 
including rhinovirus C (RV-C)1–5, human metapneumovirus6, human bocavirus (HBoV)7, and several novel coro-
naviruses, SARS coronavirus, human coronavirus NL63, human coronavirus HKU1 and Middle East Respiratory 
Syndrome coronavirus8–15. On the other hand, existing viruses have continued to emerge or re-emerge to cause 
respiratory disease epidemics.
Enteroviruses (EVs) are small, non-enveloped, single-stranded, positive-sense RNA viruses that represent one 
of the 29 genera belonging to the family Picornaviridae. The genus now comprises 12 species, EV-A to EV-H, EV-J 
and rhinovirus A (RV-A) to RV-C (previously named human rhinovirus A to C)1–3,16,17, with > 100 immunolog-
ically distinct serotypes. In addition, we have also recently described a novel EV species in dromedary camels18. 
EVs belonging to EV-A to EV-D and RV-A to RV-C cause a wide spectrum of diseases in humans3,19,20. EV-A71, 
one of the most pathogenic EVs, causes large-scale outbreaks of hand-foot-mouth disease (HFMD) with high 
complication rates in Asia-Pacific region21,22. Other EVs may also have the potential to cause severe disease and 
deaths23.
EV-D68, a member of the species EV-D, has recently emerged in various countries. In contrast to other EVs 
which often cause systemic diseases such as HFMD, EV-D68 is mainly associated with respiratory tract infections. 
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The virus was first isolated from throat swab samples of children with bronchiolitis and pneumonia in California 
in 1962 and referred as “Fermon virus”24. Rhinovirus 87 (RV87) and EV-D68 are now considered as the same 
virus with both RV and EV features (genetically related to other EVs but more temperature- and acid-labile)25,26. 
EV-D68 mainly affects infants, children and adolescents, while infections in adults were less commonly reported. 
Clinical manifestations of EV-D68 infections mainly resemble influenza-like illness, but life-threatening infec-
tions were also reported16,27–31. Neurological involvement, ranging from encephalomyelitis to acute flaccid paral-
ysis, was rare, although a recent report highlighted possible association with acute flaccid myelitis16,32,33. Based on 
sequences of the viral capsid gene VP1, EV-D68 strains are often categorized into 3 distinct genetic groups, clade 
A to C, in addition to the original Fermon lineage29,33.
Subsequent to its first isolation, EV-D68 infections have only been rarely reported in the following decades. In 
US, only 26 cases of EV-D68 infections were detected by passive EV surveillance from 1970 to 200534. However, 
increasing reports of EV-D68 infections have recently been noted in various countries from Africa, America, Asia 
and Europe27–29,31,35–37. Since August 2014, more than 1000 cases of EV-D68 have been reported in the United 
States (US), with at least 14 potentially fatal cases31. In Hong Kong, unlike EV-A71 infection which is a notifiable 
disease, the prevalence of EV-D68 was largely unknown. However, a fatal case of EV-D68 was recently reported 
in a 10-year-old boy who presented with respiratory symptoms and complicated by encephalitis (http://www.
chp.gov.hk/en/view_content/36405.html). To better define the disease impact and clinical spectrum of EV-D68, 
we examined the clinical and molecular epidemiology of EV-D68 among hospitalized patients with suspected 
respiratory virus infections in Hong Kong. The partial VP1, 2C and 3D genes of EV-D68 strains were sequenced 
to study the genetic diversity and evolutionary dynamics.
Results
Detection of EV-D68 from NPAs. A total of 6800 NPAs were subject to EV detection by RT-PCR and 
sequencing of partial 5′ UTR region. Samples positive for EVs were then subject to EV-D68 detection by RT-PCR 
and sequencing of VP1 region using EV-D68-specific primers. VP1 gene analysis showed that 30 (0.44%) NPAs 
were positive for EV-D68. The annual incidence rates were 0.27% (4/1500), 0.4% (6/1500), 0.62% (8/1300), 0.46% 
(6/1300) and 0.5% (6/1200) in year 2010, 2011, 2012, 2013 and 2014 respectively (Fig. 1). The peak season of 
EV-D68 usually occurred in late-spring/summer (May to August), except in 2011 when more cases were detected 
in late-autumn/early-winter (October to December).
Clinical characteristics of patients with EV-D68 infections. A bimodal age distribution was observed 
among the 30 patients (male: female = 19:11) with EV-D68 infections (Table 1), which included 22 children (< 18 
years), one 37-year-old adult and seven elderlies (> 60 years). Of the seven elderlies, two resided in elderly homes 
(patients 19 and 23). A 15-year-old adolescent (patient 6) and a 37-year-old adult (patient 13) were also institu-
tionalized. Close contacts of three patients were noted to have recent respiratory illnesses, including siblings of 
patients 3 and 4, and domestic helper of patient 28. One elderly (patient 20) had recent travel history to mainland 
China. No epidemiological linkage was identified among the 30 patients.
Twenty-two patients had underlying diseases, such as respiratory diseases and allergies. Most patients pre-
sented with acute respiratory illness. Sixteen patients (53%), including five elderlies, presented with pneumonia 
which represented the most common diagnosis. One elderly (patient 23) with pneumonia was complicated by 
congestive heart failure. Various radiological abnormalities were observed, including perihilar haziness, focal 
haziness, infiltrates and consolidation. Three patients (10%) presented with acute bronchiolitis or bronchitis. 
Exacerbations of small airway diseases were common, including asthmatic attacks (n = 13), febrile wheeze (n = 2) 
and exacerbation of chronic obstructive pulmonary disease (n = 2). Five patients (17%) presented with upper 
respiratory tract infection (URTI), including a 63-year-old elderly (patient 21) who was complicated by acute 
coronary syndrome and shock. Another 2-year-old girl (patient 2) with acute bronchiolitis was complicated by 
intestinal obstruction. All patients recovered. Except for a 6-year-old girl (patient 29) with influenza C virus 
co-infection, no respiratory viruses or bacteria were identified from other patients.
Molecular epidemiology of EV-D68 circulating in Hong Kong. Phylogenetic analysis of partial VP1, 
2C and 3D regions showed that the 30 EV-D68 strains fell into two major clades, clades A and B, corresponding 
to the two of the three EV-D68 clades described previously (Fig. 2 and Supplementary Fig. 1)33,35. Previous studies 
have also revealed further subgroups, such as clade B1 and B2 among strains recently emerged in US30,33,38. Upon 
VP1 analysis, 15 strains belonged to clade B, some of which being closely related to recent B1 strains from US. 
Five strains detected in 2014 form a potentially new clade, B3, together with strains from Taiwan and mainland 
China. The other 15 strains belonged to clade A, which can be further divided into two subclades, A1 (n = 2) and 
A2 (n = 13). Analysis of 2C and 3D sequences showed similar clustering (Supplementary Fig. 1). The four circu-
lating lineages, clade A1, A2, B1 and B3, shared ≥ 91.8% aa identities to each other in partial VP1 and displayed 
distinct amino acid polymorphisms in VP1, 2C and 3D (Supplementary Table 2 and Supplementary Fig. 2).
The four clades appeared to dominate in different years. While both clade A1 and B1 were detected in 2010, 
clade A1 was not detected in subsequent years. Both clade A2 and B1 were co-circulating in 2011 and 2012. 
However, clade A2 and B was the only circulating lineage in 2013 and 2014 respectively. Moreover, A2 strains 
circulating in 2013 were clustered together, as with B3 strains in 2014 (Fig. 2), suggesting epidemics from specific 
lineages. The B3 strains were only distantly related to recent B1 strains in US, suggesting the recent emergence 
of this novel subclade. Interestingly, adults/elderlies infected by EV-D68 were exclusively associated with clade 
A2, including five closely related strains from elderlies in 2013. Closely related B3 strains were also noted in six 
children in 2014.
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Detection of positive selection in VP1 genes. To assess adaptive evolution of EV-D68, dN/dS ratios (ω ) 
in VP1 gene across the 30 strains were calculated on codon-by-codon basis. The overall ω was 0.077, with most 
residues having ω < 1, indicating purifying selection (Fig. 3). Nevertheless, residues 97 and 140 (within BC and 
DE-surface loops respectively) had ω > 1 but without statistical significance, indicating possible functional con-
straints during evolution. The dominant aa compositions at BC and DE-surface loops are shown in Fig. 4.
Discussion
Our study represents the first to demonstrate EV-D68 as a possible cause of severe respiratory illness in adults 
or elderlies with underlying co-morbidities. In contrast to paediatric population, the role of EV-D68 in adult 
infections was less clear with only scarce reports. In the Netherlands, EV-D68-related respiratory illness has been 
described in adults but without clinical details27,29. Two reports from China have identified 13 and two adults 
respectively with URTIs due to EV-D6828,39. A recent report from Denmark identified EV-D68 infections in two 
adults with URTIs and one adult co-infected by RV with fever, cough and breathing difficulties30. In this study, 
only one elderly presented with URTI alone, while another elderly with URTI was complicated by acute coronary 
syndrome. The other five elderlies presented with pneumonia, with two having respiratory or cardiac complica-
tions. Another 37-year-old adult also presented with pneumonia. Our findings suggested that EV-D68 can cause 
severe infections in adults or elderlies with underlying diseases.
Figure 1. Seasonal distribution of EV-D68 in Hong Kong from 2010 to 2014. Bar graph shows percentage 
of NPAs positive for EV-D68 in each month and line graph shows monthly average temperatures (°C) in Hong 
Kong.
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4Scientific RepoRts | 6:25147 | DOI: 10.1038/srep25147
The EV-D68 infections in adults or elderlies may be underdiagnosed. The conserved 5′ UTR is a common 
target for initial RT-PCR detection of EVs, while specific diagnosis of EV-D68 usually relies on specific RT-PCR 
assays or VP1 sequencing. In particular, a number of EV-D68 specific diagnostic tools based on real-time PCR 
assays have been developed recently40–42. Although commercially available multiplex PCR assays may include 
EV-D68, they may lack sensitivity and specificity, and may not differentiate EV-D68 from RVs42. Moreover, 
EV-D68 is seldom included in diagnostic panels for respiratory viruses, while most surveillance programs for 
EVs focus on stool samples. Inclusion of EV-D68 in routine respiratory virus panels may also help better assess 
its clinical and public health significance.
The present study also represents the first to describe the epidemiology of EV-D68 infections in Hong Kong. 
The steady annual incidence observed suggested that EV-D68 has been circulating for at least several years. 
Unlike EV-A71 with seasonal peaks during summer/fall, as many as 50% of EV-D68 infections may fall outside 
usual EV peak seasons34,43,44. EV-D68 appears to peak during spring/summer in our population, while a delayed 
autumn/winter peak was observed in 2011. Therefore, factors other than temperature may also play a role in 
the seasonality of EV-D68 infection. Lower respiratory illness was common among both elderlies and children, 
with pneumonia being the most common diagnosis. Many patients were also complicated by exacerbation of 
Patient no. Month/year Sex Age Underlying disease Diagnosis Clade CXR findings
1 Jun/2010 F 2 None Hand-foot-mouth disease A1 NA
2 Jun/2010 F 2 Prematurity, short gut syndrome on TPN, global developmental delay
Acute bronchiolitis, intestinal 
obstruction A1 NA
3 Jul/2010 M 11m None Pneumonia B1 Bilateral upper zone haziness
4 Aug/2010 F 5 None Pneumonia, asthma B1 Diffuse haziness especially at perihilar region and RLZ
5 Aug/2011 M 7 None Pneumonia, asthma A2 Perihilar haziness
6 Oct/2010 M 15 Asthma, ezcema Asthma A2 NA
7 Nov/2011 M 6 Eczma, febrile convulsion Asthma A2 NA
8 Dec/2011 F 6 None Pneumonia, asthma B1 Perihilar haziness
9 Dec/2011 F 4 Down syndrome, AML URTI B1 NA
10 Dec/2011 M 8 Hyperpigmentation, asthma Acute bronchiolitis, asthma B1 NA
11 Mar/2012 F 77 HT, CA lung URTI A2 Blunted right costophrenic angle
12 May/2012 M 6 None Pneumonia, asthma B1 Perihilar haziness
13 May/2012 M 37 Severe mental retardation Pneumonia A2 Bilateral lower zone infiltrates
14 Jun/2012 M 7 Asthma, ezcema Pneumonia, asthma B1 Right perihilar haziness
15 Jun/2012 F 10 Asthma, ezcema Asthma B1 NA
16 Jul/2012 F 6 Allergic airway Pneumonia, asthma B1 Mild bilateral haziness
17 Aug/2012 F 14m Prematurity, biliary atresia with LLDT URTI A2 NA
18 Sep/2012 F 77 COPD, bronchiectasis, CHF Pneumonia, COPD exacerbation A2 RLZ haziness
19 Jun/2013 M 75 NPC, pituitary macroadenoma, panhypopituitarism Pneumonia A2 RLZ infiltrates
20 Jun/2013 M 82 HT, old PTB Pneumonia A2 RLZ consolidation
21 Jul/2013 M 63 HT, tetralogy of Fallot, monomorphic VT on ICD URTI, ACS, ICD shock A2 NA
22 Aug/2013 M 83 HT, COPD, lacunar infarct Pneumonia, COPD exacerbation A2 RLZ infiltrates
23 Aug/2013 M 94 DM, AF, IHD, CHF, old PTB Pneumonia, CHF A2 RLZ haziness
24 Oct/2013 M 3 Prematurity, cerebral palsy, epilepsy, cortical blindness URTI A2 NA
25 Jun/2014 M 4 RSV pneumonia Acute bronchitis B3 NA
26 Jul/2014 M 5 Asthma, eczema Asthma B1 NA
27 Jul/2014 M 11 Asthma Pneumonia, asthma B3 Bilateral hilar haziness, mild peribronchial cuffing
28 Jul/2014 M 11m None Febrile wheeze B3 NA
29 Jul/2014 F 6 Reactive airway, eczema Pneumonia, asthma B3 Left perihilar haziness
30 Aug/2014 M 3 None Pneumonia, febrile wheeze B3 Perihilar haziness
Table 1.  Clinical characteristics of the 30 cases of EVD68 infections. ACS, acute coronary syndrome; AF, 
atrial fibrillation; AML, acute myeloid leukemia; CA lung, carcinoma of lung; CHF, congestive heart failure; 
COPD, chronic obstructive pulmonary disease; DM, diabetes mellitis; HT, hypertension; ICD, implantable 
cardioverter defibrillator; IHD, ischemic heart disease; LDLT, living donor liver transplantation; NA, no 
abnormalities; NPC, nasopharyngeal carcinoma; PTB, pulmonary tuberculosis; RLZ, right lower zone; RSV, 
respiratory syncytial virus; TPN, total parenteral nutrition; URTI, upper respiratory tract infection; VT, 
ventricular tachycardia.
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Figure 2. Phylogenetic trees of the partial VP1 regions of EV-D68 strains in Hong Kong. 1004 nucleotide 
positions were included in the analysis. Strains detected in this study were marked with triangles. Strains 
detected during the epidemic in US in 2014 were highlighted in light gray. The tree was rooted with the original 
lineage including the prototype strain Fermon (Genbank accession no. AY426531). The scale bar indicates the 
estimated number of substitutions per 50 bases.
www.nature.com/scientificreports/
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small airway disease, in line with the disproportionate presence of asthma among cases in US45. Interestingly, 
a 2-year-old girl (patient 1) had hand-foot-mouth disease which has not been previously reported for EV-D68, 
although the possibility of co-infection by other EVs cannot be excluded. However, given the limited number of 
positive samples in this study, further epidemiology studies with inclusion of more cases are required to assess the 
seasonality, epidemiology and disease impact of EV-D68 in our population.
Our results revealed four lineages of EV-D68, A1, A2, B1 and B3, having circulated in our population and the 
potential emergence of a new subclade B3 in 2014. Moreover, adults/elderlies were infected exclusively by clade 
A2, suggesting that this lineage may be emerging in our elderly population. The recent emergence of EV-D68 
Figure 3. The ratio of nonsynoymous to synonymous substitutions (ω = dN/dS) per codon site in the VP1 
region of the 30 EV-D68 strains. Residues with ω > 1 were likely to have evolved under positive selection. 
Codon position was based on the EV-D68 prototype strain Fermon.
Figure 4. Relative residue abundance in the BC (a) and DE (b) surface-exposed loops of VP1 among lineage 1 
and 2 strains. The graphical representation was generated using WebLogo. The height of symbol indicates the 
relative frequency of the corresponding amino acid. Amino acid position was based on the EV-D68 prototype 
strain Fermon.
www.nature.com/scientificreports/
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in different countries may be due to viral evolution of strains/lineages with different antigenicity, with major 
bifurcation of currently circulating EV-D68 strains dated back to around 194533,35,39. The aa sequence patterns 
in BC and DE-surface loops, which determine the antigenic epitopes, may correlate with lineage classification35. 
The four lineages in this study also possessed distinct aa sequence patterns in BC and DE loops (Supplementary 
Fig. 2a). Moreover, most B strains circulating in 2014 formed a new separate subclade, B3, only distantly related 
to recent B1 sand B2 trains from US. Other potential B3 strains were also detected in Beijing and Taiwan in 2014 
(Fig. 2). On the other hand, some of our B strains detected as early as 2011 were closely related to B1 strains from 
US. Our findings suggested that the recent epidemic in US may have originated from strains circulating in Asia 
several years ago, while a new lineage, B3, has only recently emerged in Hong Kong and neighbouring regions. 
More sequence data are needed to understand the genetic changes that may have driven the emergence of new 
lineages of EV-D68.
Different EVs are known to utilize difference receptors for cellular entry, which may explain their diverse 
clinical manifestations and tissue tropisms. In contrast to most EVs with enteric tropism, EV-D68 is seldom 
detected from stool of infected patients. Although EV-D68 possessed some properties of RVs, it does not utilize 
the receptors of RVs, namely intercellular adhesion molecule 1 (ICAM-1) or low-density lipoprotein receptor 
(LDL-R)46,47. Instead, it shares the same receptor, decay accelerating factor (DAF), with EV-D70 and several echo-
virus serotypes25,48,49. Interestingly, both EV-D68 and EV-D70 belong to the species EV-D, although EV-D70 is 
mainly associated with acute hemorrhagic conjunctivitis19. In addition, EV-D68 may use sialic acids as receptor, 
with preferential binding α 2–6-linked sialic acids (α 2–6 SAs) than to α 2–3 SAs, which may suggest higher affin-
ity for upper respiratory epithelium47,50. Since our results suggest that lower respiratory illness can be common 
in EV-D68 infections, further studies are required to investigate if some strains or lineages may possess higher 
affinity for the lower airway.
Methods
Ethics statement. The ethical approval was given by the Institutional Review Board of the University of 
Hong Kong/Hospital Authority Hong Kong West Cluster (UW 04-278 T/600), and the study was conducted in 
compliance with the principles of the Declaration of Helsinki. Consents for the use of the clinical samples were 
waived because only left-over samples were used.
Patients and microbiological methods. All NPAs were collected from hospitalized patients in two 
regional hospitals in Hong Kong during a five-year period (January 2010 to December 2014), and were tested 
negative for influenza A and B viruses, parainfluenza viruses types 1, 2 and 3, respiratory syncytial virus, adeno-
virus, human metapneumovirus, human coronaviruses and human bocavirus2.
RT-PCR for detection of EV-D68 from NPAs. RNA extraction and RT-PCR for EVs were performed 
using previously described protocols with modifications and primers targeted to the 5′ untranslated region 
(5′ UTR) as shown in Supplementary Table 12,51. Both strands of PCR products were sequenced twice with an 
ABI 3130xl DNA Analyzer (Applied Biosystems), using the PCR primers. Nucleotide sequences were compared 
to those of known EVs with sequences available in GenBank. Positive samples with sequences belonging to 
EVs were subject to EV-D68 detection by RT-PCR and sequencing of VP1 gene using EV-D68 specific primers. 
Samples containing EV-D68 upon VP1 gene sequencing were further subject to 2C and 3D gene sequencing.
RT-PCR and sequencing of VP1, 2C and 3D gene regions. The partial VP1, 2C and 3D gene regions of 
EV-D68 strains detected from NPAs were amplified and sequenced using primers shown in Supplementary Table 1 
and previously described protocols with modifications2,52. Phylogenetic trees of each region were constructed 
using maximum likelihood (ML) method in MEGA6, with bootstrap analysis of 1000 replicates.
Selective pressure analysis. The number of synonymous substitutions per synonymous site, dS, and 
non-synonymous substitutions per non-synonymous site, dN, in VP1 were calculated using Nei-Gojobori method 
(Jukes-Cantor) in MEGA5. Sites under positive selection were inferred using single-likelihood ancestor counting 
(SLAC) and fixed effects likelihood (FEL) methods as implemented in DataMonkey server (http://www.datamon-
key.org). The overall ω (dN/dS) value was calculated according to NJ trees under the TrN93 substitution model. 
Positive selection for a site was considered to be statistically significant if P-value was < 0.1. A mixed-effects model 
of evolution (MEME) was further used to identify positively selected sites under episodic diversifying selection in 
particular positions among different clades within a phylogenetic tree even when positive selection is not evident 
across the entire tree. The relative residue abundance within BC and DE-surface exposed loops were depicted using 
WebLogo.
Nucleotide sequence accession number. The sequences of EV-D68 strains have been lodged within 
GenBank under accession no. KT959173-KT959202 (VP1), KT959113-KT959142 (2C), and KT959143-KT959172 
(3D).
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